Evidence-Based, Patient-Centered Dose Optimization Across Diverse Early R/R MM Treatment Regimens

Evidence-Based, Patient-Centered Dose Optimization Across Diverse Early R/R MM Treatment Regimens

Are you struggling to optimize dosage, titration, and modification strategies with early relapsed/refractory multiple myeloma treatment regimens for individual patients? Test your skills and gain expertise with this interactive case-based challenge, designed to support you to apply evidence-based dose optimization and patient medication education.

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/evidence-based-patient-centered-dose-optimization-across-diverse-early-r-r-mm
  • Start Date: 2024-10-30 05:00:00
  • End Date: 2024-10-30 05:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.25 hours
    AMA PRA Category 1 Credit™️: 0.25 hours
    Nursing: 0.25 hours
    Pharmacy: 0.25 hours
  • MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: Sanofi S.A. - Amount: 19875.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Hematology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.